Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Gerald Willimsky

Professor

Charité - Universitätsmedizin Berlin

Germany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Articles (11)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

Ulrich Keller

Prof. Dr.

Charité - Universitätsmedizin Berlin

GERMANY

View details

Matthias Leisegang

Associate Professor

Otto-von-Guericke Universität Magdeburg

GERMANY

View details

Stefan Jordan

Heidelberg University

GERMANY

View details

Jan Krönke

Professor

Charité - Universitätsmedizin Berlin

GERMANY

View details

Frank Heppner

Director

Charité - Universitätsmedizin Berlin

GERMANY

View details

Lukas John

Deutsches Krebsforschungszentrum

GERMANY

View details

Steven Wolf

University of Chicago

UNITED STATES

View details

Günther Schönrich

Professor

Charité - Universitätsmedizin Berlin

GERMANY

View details

Angelika Riemer

Division Head

Deutsches Krebsforschungszentrum

GERMANY

View details

Kai Diederich

Federal Institute for Risk Assessment

GERMANY

View details

Bjoern Chapuy

Professoor

Charité - Universitätsmedizin Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gerald Willimsky

Research Interests

Make your next move.

Explore related searches

Articles (11)

A CD22-specific T-cell receptor enables effective adoptive T-cell therapy for B-cell malignancies

Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire

Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma

A phase I study of MAGE-A1-targeted T1367 T-cell receptorbased cell therapy in patients with advanced multiple myeloma.

Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancer.

T cell receptors specific for an imatinib-induced mutation in BCR-ABL for adoptive T cell therapy.

Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure.

A facility for laboratory mice with a natural microbiome at Charité - Universitätsmedizin Berlin.

Early protective effect of a ("pan") coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration.

Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al

Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors.

Collaborators (11)

Ulrich Keller

Matthias Leisegang

Stefan Jordan

Jan Krönke

Frank Heppner

Lukas John

Steven Wolf

Günther Schönrich

Angelika Riemer

Kai Diederich

Bjoern Chapuy

Make your next move.